| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 2.294 | 59.050 | 48.064 | 59.298 |
| Total Income - EUR | - | - | - | - | - | - | 2.294 | 59.050 | 48.064 | 59.298 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.173 | 75.734 | 73.809 | 64.583 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.121 | -16.684 | -25.745 | -5.285 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.054 | -17.275 | -26.226 | -5.878 |
| Employees | - | - | - | - | - | - | 0 | 3 | 3 | 3 |
Check the financial reports for the company - Naturalex Bios S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | 23.335 | 19.303 | 17.622 | 20.951 |
| Inventories | - | - | - | - | - | - | 20.902 | 19.182 | 12.482 | 21.241 |
| Receivables | - | - | - | - | - | - | 2.335 | 57 | 625 | 40 |
| Cash | - | - | - | - | - | - | 99 | 65 | 4.515 | -330 |
| Shareholders Funds | - | - | - | - | - | - | 1.094 | -16.177 | -42.354 | -47.995 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | 22.241 | 35.480 | 59.975 | 68.947 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4779 - 4779" | |||||||||
| CAEN Financial Year |
4779
|
|||||||||
Comments - Naturalex Bios S.r.l.